VA 急诊科的听力障碍、策略和结果 (HearVA-ED)
实施 HearVA (I-HearVA)
HearVA involves six VA facility emergency departments (ED) over a 3-year intervention period. The first part of this study will test whether providing personal amplifiers to Veteran ED patients who self-report hearing difficulty is acceptable to these patients, can improve their hearing, enhance understanding of discharge instructions, and can reduce the risk of coming back to the ED in a short period of time (3 days and 30 days). The second part of the study will then identify whether ED staff can implement this program and achieve similar results. The second part will give ED staff increasing levels of responsibility for screening Veterans for hearing difficulty and providing personal amplifiers when such difficulty is detected.
研究概览
详细说明
HearVA is a randomized controlled trial to explore the utility and outcomes of providing point-of-care access to hearing-impaired Veterans, comparing an offer of personal amplifiers versus control in an environment where the clinical stakes are high. It addresses a knowledge gap about the utility of providing such hearing assistance during clinical encounters. The study measures whether providing personal amplifiers is acceptable to older patients, can improve hearing, enhance understanding of discharge instructions, and improve care transitions at discharge. If such a strategy is beneficial, this simple low-tech approach has great potential for implementation and wide dissemination. HearVA-ED has two phases - the first, which has been completed, established the feasibility and acceptability of research and procedures in the ED environment through a pilot efficacy study and the second phase will be to complete a larger more definitive efficacy study and a detailed implementation study resulting in a strategic approach that can be widely disseminated across all VA emergency departments throughout the United States. This second phase will use a mixed-methods, hybrid effectiveness-implementation design to implement and evaluate the hearing assistance intervention in six VA Emergency Department Sites (in different facilities across the country). Implementation will occur in four stages with variation in the starting sequence at each site: The first group of two VA emergency departments will initiate implementation with an efficacy trial; second group of two sites will initiate implementation with delivery and support of personal amplifiers after screening and randomization by a research assistant (Stage 1); the third group of two sites will initiate implementation with the entire implementation (Stage 2) and the presence of a research assistant to conduct discharge interviews; and all sites will progress from this sequence to Stage 3 - Sustainability - which is the full implementation without research assistant presence.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Joshua Chodosh, MD MSHS
- 电话号码:48491 (310) 478-3711
- 邮箱:Joshua.Chodosh@va.gov
研究联系人备份
- 姓名:Lin T Tun
- 电话号码:(646) 501-4132
- 邮箱:lin.tun@va.gov
学习地点
-
-
Colorado
-
Aurora、Colorado、美国、80045-7211
- 招聘中
- Rocky Mountain Regional VA Medical Center, Aurora, CO
-
接触:
- Lauren Abbate, MD
- 电话号码:3177 303-399-8020
- 邮箱:lauren.abbate@va.gov
-
-
New York
-
New York、New York、美国、10010-5011
- 招聘中
- VA NY Harbor Healthcare System, New York, NY
-
首席研究员:
- Joshua Chodosh, MD MSHS
-
接触:
- Olga Dotsenko
- 电话号码:3323 (212) 686-7500
- 邮箱:olga.dotsenko@va.gov
-
接触:
- Andrea M Aquines
- 电话号码:(212) 686-7500
- 邮箱:andrea.aquines@va.gov
-
Syracuse、New York、美国、13210-2716
- 主动,不招人
- Syracuse VA Medical Center, Syracuse, NY
-
The Bronx、New York、美国、10468
- 招聘中
- James J. Peters VA Medical Center, Bronx, NY
-
接触:
- Ula Hwang, MD
- 电话号码:3816 718-584-9000
- 邮箱:ula.hwang@va.gov
-
-
North Carolina
-
Durham、North Carolina、美国、27705-3875
- 招聘中
- Durham VA Medical Center, Durham, NC
-
接触:
- Luna Ragsdale, MD
- 邮箱:luna.ragsdale@va.gov
-
-
Texas
-
Dallas、Texas、美国、75216-7167
- 招聘中
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
-
接触:
- Rohit Manaktala, MD
- 邮箱:Rohit.Manaktala@va.gov
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- English speaking
- Emergency severity index criterion of 3 (medium), 4, or 5 (low acuity)
- Hearing Handicap Inventory-Screen greater than or equal to 10 or positive answer to a single-item screening question
- Capacity to consent to participate in research
Exclusion Criteria:
- Inability to consent to participate in research
- Emergency severity index criterion of 1-2 (high acuity)
- Hearing Handicap Inventory-Screen less than 10 and negative answer to single item screening question
- Inability to speak English
- Using cochlear implants
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Intervention: Personal Amplifier
Consenting participants will be randomly assigned to the intervention group while receiving care in the emergency department |
The intervention group will receive personal amplifiers (PockeTalkers) while they receive care in the ED
其他名称:
|
|
其他:Control: No Personal Amplifier
Consenting participants will be randomly assigned to the control group while receiving care in the emergency department |
The control group will not receive personal amplifiers while they receive care in the ED |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Emergency department (ED) 3-day Readmissions
大体时间:3-5 days after initial ED stay
|
The Investigators will determine whether patients have had an ED revisit within three days through CPRS review as well as a brief follow-up phone call 3-5 days after ED discharge |
3-5 days after initial ED stay
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Emergency department (ED) 30-day Readmissions
大体时间:30-35 days after initial ED stay
|
The Investigators will determine whether patients have had an ED revisit within 30 days through CPRS review as well as a brief follow-up phone call 30-35 days after ED discharge |
30-35 days after initial ED stay
|
|
Patient-Rated Quality of Hearing, Understanding, and Communication With Providers During Emergency department (ED) Stay
大体时间:Duration of ED stay, average of 1 day
|
Participants will self-rate their quality of hearing, understanding, and communication using a six item questionnaire. Scored on a 10-point Likert scale (1 = do not agree at all; 10 = completely agree) the questions will be: When I talked to the doctors and nurses today ... (1) their voices were very clear; (2) I was able to hear the sounds that I wanted to hear; (3) noises did not cause a problem for my hearing; and (4) listening did not make me tired. Two additional statements will explicitly capture understanding: (5) I was able to understand what they said; and (6) I was able to understand without making an effort. Higher scores will indicate better communication and understanding with providers. |
Duration of ED stay, average of 1 day
|
|
Patient-Rated Quality of Post-Discharge Care
大体时间:At time of discharge from ED, average 1 day
|
Patient-rated quality of post-discharge care using a three-item subset of the Care Transition Measure (CTM). The questions are scored on a 1-4 scale (1= strongly disagree; 4 = strongly agree): (1) The ED staff considered my preferences and those of my family or caregiver in deciding what my healthcare needs were for discharge; (2) Leaving the ED, I have a good understanding of the things I am responsible for in managing my health; (3) Leaving the ED, I clearly understand the purpose for each of my medications. Higher scores will indicate better discharge preparation. |
At time of discharge from ED, average 1 day
|
|
Self-Reported Understanding of Discharge Instructions
大体时间:3-5 days after initial ED stay
|
Investigators will gauge self-reported understanding of discharge instructions using semi-structured interview data compared to documented discharge data. |
3-5 days after initial ED stay
|
合作者和调查者
调查人员
- 首席研究员:Joshua Chodosh, MD MSHS、VA NY Harbor Healthcare System, New York, NY
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.